|
www.StockMarketingInc.com: Unbelievable News!!!! (FORC) Force Energy Corp. Announces $5 Million Equity Financing!!!!!!!
Oct 07, 2009 (M2 PRESSWIRE via COMTEX) --
STOCK MARKETING INC PRESENTS :
(OTCBB: FORC) Force Energy Corp.
(NASDAQ: ANAD) ANADIGICS, Inc.
(NASDAQ: ARTX) Arotech Corp.
(NASDAQ: ATHN) athenahealth, Inc.
(NASDAQ: ATML) Atmel Corp.
(NASDAQ: ATRC) AtriCure, Inc.
www.StockMarketingInc.com
To sign up for our free Profiles & Alerts :: visit http://www.StockMarketingInc.com
Email us!! info@StockMarketingInc.com OR CALL 1-866-583-8960
------------------------------------------------------------------------------------------------------------------------------------------------------------
(OTCBB: FORC) Force Energy Corp.
BREAKING NEWS!!
Force Energy Corp. Announces $5 Million Equity Financing
DENVER, COLORADO, Oct 7, 2009 -- Force Energy Corp. (OTCBB:FORC)(FRANKFURT:FC2) (hereafter "Force", "the Company"), is pleased to announce that the company has entered into a financing agreement with Banque SCS Alliance, whereby the Swiss based banking group will invest up to $5 million into Force Energy Corp.
The financing agreement is equity based and market condition dependent. The agreement may be receded by either party with 30 days notice. Funds will be used to advance drilling activities on the Diamond Springs Prospect as well as for general working capital and investment purposes. Force Energy has secured only traditional equity financing.
"We are pleased to have Bank SCS Alliance in our corner." Said Rahim Rayani, President & CEO of Force Energy Corp. "This financing agreement will allow the Company to execute on our plans to explore and develop the Diamond Springs Prospect."
The securities offered have not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent a registration or an applicable exemption from the registration requirements.
About Force Energy Corp.
Force Energy Corp. is an Oil & Gas Exploration and Development Company based in Denver, CO with a focus on Wyoming. Using a geology-based methodology, the US Geological Survey estimate a mean of 2.4 trillion cubic feet of undiscovered natural gas and a mean of 41 million barrels of undiscovered oil in the Wind River Basin Province of Wyoming. Force Energy Corp. has acquired 75% working interest in the Diamond Springs Prospect located within this prolific area. The Company's shares are publicly traded on the OTCBB under the ticker symbol FORC.
On behalf of the Board of Directors
FORCE ENERGY CORP.
Legal Notice Regarding Forward-Looking Statements
Legal Notice Regarding Forward-Looking Statements in this news release that are not historical facts are forward-looking statements that are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined, and assumptions of management. Forward looking statements are generally, but not always, identified by the words "expects", "plans", "anticipates", "has", "believes", "intends", "estimates", "projects", "aims", "potential", "goal", "objective", "prospective", and similar expressions or that events or conditions "will", "would", "may", "can", "could" or "should" occur. Information concerning oil or natural gas reserve estimates may also be deemed to be forward looking statements, as it constitutes a prediction of what might be found to be present when and if a project is actually developed.
Actual results may differ materially from those currently anticipated due to a number of factors beyond the reasonable control of the Company. It is important to note that actual outcomes and the Company's actual results could differ materially from those in such forward-looking statements. Factors that could cause actual results to differ materially include misinterpretation of data, inaccurate estimates of oil and natural gas reserves, the uncertainty of the requirements demanded by environmental agencies, the Company's ability to raise financing for operations, breach by parties with whom we have contracted, inability to maintain qualified employees or consultants because of compensation or other issues, competition for equipment, inability to obtain drilling permits, potential delays or obstacles in drilling operations and interpreting data, the likelihood that no commercial quantities of oil or gas are found or recoverable, and our ability to participate in the exploration of, and successful completion of development programs on all aforementioned prospects and leases. Additional information on risks for the Company can be found in filings on Edgar of other junior oil and gas exploration companies with the US Securities and Exchange Commission.
SOURCE: Force Energy Corp.
CONTACT: Investor Relations Force Energy Corp.
Rahim Rayani, President & CEO 1-866-953-FORC (3672) ir@forceenergycorp.com www.forceenergycorp.com
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: ANAD) ANADIGICS, Inc.
BREAKING NEWS!!
ANADIGICS Sets Date for Third Quarter 2009 Earnings Release and Conference Call
WARREN, NJ, Oct 06, 2009 -- ANADIGICS, Inc. (NASDAQ: ANAD), a leading global supplier for the communications markets, will host a conference call with the investment community to discuss third quarter 2009 results and business outlook on October 27, 2009 at 5:00 pm Eastern time.
After the close of market, and prior to the conference call, ANADIGICS will issue a copy of the earnings press release. The conference call will be webcast live on the Company's Web site at http://www.anadigics.com/investors.
Playback of the conference call will be available approximately one hour after the call's completion and can be accessed by dialing 800-642-1687, conference ID number 34535466. The replay will be available until November 3, 2009.
About ANADIGICS, Inc.
ANADIGICS, Inc. (NASDAQ: ANAD) is a leading provider of semiconductor solutions in the rapidly growing wireless handset and broadband communication markets. Founded in 1985 and headquartered in Warren, NJ, the company's award-winning products include power amplifiers for wireless handsets, WLAN and WiMAX; CATV tuner integrated circuits, active splitters and CATV infrastructure line amplifier ICs, which can be sold individually or packaged as integrated RF and front end modules. For more information, visit: www.anadigics.com.
Except for historical information contained herein, this press release contains forward-looking statements that involve risks and uncertainties, including, but not limited to, order rescheduling or cancellation, changes in customers' forecasts of product demand, timely product and process development and protection of the associated intellectual property rights, individual product pricing pressure, variation in production yield, changes in estimated product lives, difficulties in obtaining components and assembly and test services needed for production of integrated circuits, change in economic conditions of the various markets the Company serves, as well as the other risks detailed from time to time in the Company's reports filed with the Securities and Exchange Commission, including the report on Form 10-K for the year ended December 31, 2008. Actual results could differ materially from the Company's forward-looking statements. These forward-looking statements can generally be identified as such because the context of the statement will include words such as "believe", "anticipate", "expect", or words of similar import. Similarly, statements that describe the Company's future plans, objectives, estimates, or goals are forward-looking statements. Important factors that could cause actual results and developments to be materially different from those expressed or implied by such statements include those factors discussed herein.
Investor Relations Thomas Shields ANADIGICS, Inc.
141 Mt. Bethel Road Warren, NJ 07059 Tel: +1 908 412-5995 e-mail: tshields@anadigics.com
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: ARTX) Arotech Corp.
BREAKING NEWS!!
Arotech and Israel Military Industries Ltd (IMI) to Jointly Market the David
The Land Rover-Based Armored David Is Widely Used by Israel's Military
WASHINGTON, DC, Oct 06, 2009 -- Arotech Corporation (NASDAQ: ARTX) announced today that its Armor Division has signed an agreement with Israel Military Industries Ltd (IMI) to jointly market the MDT David in markets worldwide. IMI's Land Systems Division has been specializing in development, integration and production of combat proven systems for Main Battle Tanks (MBT) and Armored Personnel Carriers to the Israel Defense Forces (IDF) and selected customers around the world. Drawing on its worldwide armor marketing network, IMI will now also be able to offer a lightweight combat vehicle with extensive IDF experience -- The David.
The David is a lightweight armored vehicle based on a Land Rover heavy duty Defender platform. The David has been selected by the Israel Defense Force (IDF) as its standard armored reconnaissance and patrol vehicle, and is operating hundreds of them already.
The David has been involved in numerous terror attacks, withstanding assault weapons and various explosive devices, saving the lives of its occupants.
The Agreement does not cover areas where MDT is currently actively involved, such as the US, India and Israel. The Agreement was signed yesterday at the Arotech display at the Annual Meeting of the Association of the US Army (AUSA) in Washington, DC. Arotech's Armor Group's AUSA display includes the David and other armor products.
"The David has proven itself time and again," said Robert Ehrlich, Arotech's Chairman and CEO. "With this joint marketing program we will be able to offer the David to customers worldwide."
About Israel Military Industries Ltd (IMI)
IMI is located in Ramat Hasharon, Israel and provides a broad range of vehicle protection system solutions. IMI is a diversified, high-technology company specializing in the development, manufacturing and deployment of a wide range of state-of-the-art combat-ready solutions. More information about IMI can be found at www.imi-israel.com
IMI's armor solutions are on display at IMI stand #3624, at the Annual AUSA Convention in Washington, DC October 4-7, 2009.
About Arotech's Armor Division
Arotech's Armor Division is an innovative leader in lightweight armoring for vehicles, aircraft and their operators. The Armor Division has years of battlefield and commercial protection experience and has provided life saving protection under the most extreme conditions.
Arotech's Armor Division consists of MDT Armor Corporation (www.mdt-armor.com), M.D.T. Protective Industries, Ltd. (www.mdtisrael.com), and Armour of America (www.aoa-usa.com).
About Arotech Corporation
Arotech Corporation is a leading provider of quality defense and security products for the military, law enforcement and homeland security markets. Arotech provides multimedia interactive simulators/trainers, lightweight armoring and advanced zinc-air and lithium batteries and chargers. Arotech operates through three major business divisions: Armor, Training and Simulation, and Batteries and Power Systems.
Arotech is incorporated in Delaware, with corporate offices in Ann Arbor, Michigan and research, development and production subsidiaries in Alabama, Michigan and Israel.
Except for the historical information herein, the matters discussed in this news release include forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995, including the effect of any share repurchases by Arotech. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, readers are cautioned not to place undue reliance on these forward-looking statements, as they are subject to various risks and uncertainties that may cause actual results to vary materially. These risks and uncertainties include, but are not limited to, risks relating to: product and technology development; the uncertainty of the market for Arotech's products; changing economic conditions; delay, cancellation or non-renewal, in whole or in part, of contracts or of purchase orders; dilution resulting from issuances of Arotech's common stock upon conversion or payment of its outstanding convertible debt, which would be increasingly dilutive if and to the extent that the market price of Arotech's stock decreases; and other risk factors detailed in Arotech's most recent Annual Report on Form 10-K for the fiscal year ended December 31, 2008 and other filings with the Securities and Exchange Commission. Arotech assumes no obligation to update the information in this release. Reference to the Company's website above does not constitute incorporation of any of the information thereon into this press release.
CONTACT:
Victor Allgeier TTC Group (646) 290-6400 Email Contact
Jonathan Whartman MDT Armor (866) 325-6963 Email Contact
Avi Shechter IMI Services USA (301) 215-4800 Email Contact
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: ATHN) athenahealth, Inc.
BREAKING NEWS!!
athenahealth, Inc. Announces Third Quarter 2009 Earnings Conference Call
WATERTOWN, Mass., Oct 06, 2009 -- athenahealth, Inc. (NASDAQ: ATHN), a leading provider of internet-based business services for physician practices, today announced that the Company will hold a conference call for investors on Friday, October 30, 2009 at 8:00 a.m. ET. Management will discuss the Company's third quarter 2009 results, which will be released after the close of market trading on Thursday, October 29, 2009.
To participate in athenahealth's live conference call and webcast, dial 877-852-6580 (719-325-4758 for international calls) using conference code 2478148 or visit the investors section of the Company's web site: www.athenahealth.com. A replay of the conference call will be available via the website or by calling 888-203-1112 (719-457-0820 for international calls) and using conference code No. 2478148.
About athenahealth athenahealth is a leading provider of internet-based business services for physician practices. The Company's service offerings are based on proprietary web-native practice management electronic health record (EHR) software, a continuously updated payer knowledge-base and integrated back-office service operations. For more information visit www.athenahealth.com or call (888) 652-8200.
SOURCE: athenahealth
CONTACT:
(Investors) athenahealth, Inc. Jennifer Heizer, 617-402-1322 Senior Manager, Investor Relations investorrelations@athenahealth.com or (Media) athenahealth, Inc. John Hallock, 617-402-1428 Director, Corporate Communications media@athenahealth.com
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: ATML) Atmel Corp.
BREAKING NEWS!!
Atmel's AVR Microcontrollers Now Integrate RF Transmitter Functionality to Address Industrial Applications
SAN JOSE, Calif., Oct 06, 2009 -- Atmel(R) Corporation (Nasdaq: ATML) today announced the first ATA874x single-chip UHF ASK/FSK RF transmitter family targeting a broad range of proprietary wireless industrial and consumer applications such as metering, alarm systems and home control applications. This new AVR(R) product family offers industry-leading RF performance operating in the license-free ISM frequency bands (868 to 928 MHz, 433 MHz, and 315 MHz).
As a well-known market player in smart metering and home automation with its wireless IEEE 802.15.4 and ZigBee(R) products, Atmel now takes the additional step to address the requirements in the diversified proprietary wireless market segments.
With a low-power AVR CPU, a highly effective RF transmitter, and a sleep-mode power consumption of only 160 nA, the ATA874x family members are uniquely optimized to address battery-driven applications such as remote controls or garage door openers. The tiny QFN24 packages, measuring only 5 mm x 5 mm, allow the creation of extremely small designs at highly competitive costs. Customers can benefit from a bill of material (BOM) cost savings of up to 30 percent and board-area savings of up to 50 percent, when compared with conventional solutions.
These new ATA874x devices are highly integrated, and incorporate Atmel's well-accepted RF transmitter technology that have sold over 50 million units to date.
The ATA874x devices offer maximum flexibility using the ATtiny44V CPU, allowing in-system flash memory re-programming. By executing powerful instructions in a single-clock cycle, the ATtiny44V achieves throughputs approaching 1 MIPS per MHz that enable system designers to optimize power consumption versus processing speed. The powerful AVR controller simplifies hardware and software designs.
The key features of Atmel's new highly-integrated, microcontroller-based RF solution include proven technologies shipped in various products since 2001. The market-leading 8-bit microcontroller AVR CPU has been incorporated into countless products and Atmel has shipped more than a billion units. Atmel's RF technology has satisfied even the strictest quality and reliability demands of the automotive market. Customers that have worked with AVR or earlier RF products can reuse existing RF transmitter or AVR designs and software, thus reducing both development costs and time-to-market.
The ATA874x single-chip narrow band transmitter family complements the well-established Atmel ISM band receivers, such as ATA8201 and ATA8202 or ATA8203/4/5, providing a total end-to-end solution to its customers.
Availability and Pricing
Samples of the ATA874x family are now available in small-outline QFN24 packages. Pricing starts at USD $1 for quantities of 200k. To simplify and accelerate product design, a complete design kit for uni-directional RF applications, as well as Atmel's well-known AVR Studio(R) for new software development (STK512-EKx-IND), are available for customer lab measurements and performance evaluations.
Additional Information:
More information on Atmel's AVR microcontroller family ATA874x with RF transmitter functionality is available at:
http://www.atmel.com/dyn/products/product_card.asp?part_id=4634 (ATA8741)
http://www.atmel.com/dyn/products/product_card.asp?part_id=4635 (ATA8742)
http://www.atmel.com/dyn/products/product_card.asp?part_id=4636 (ATA8743)
Footnote ASK = Amplitude Shift Keying BOM = Bill of Materials FSK = Frequency Shift Keying ISP = In-System Programming MIPS = Million Instructions Per Second QFN = Quad Flat No leads UHF = Ultra High Frequency SPI = Serial Peripheral Interface
About Atmel
Atmel is a worldwide leader in the design and manufacture of microcontrollers, advanced logic, mixed-signal, nonvolatile memory and radio frequency (RF) components. Leveraging one of the industry's broadest intellectual property (IP) technology portfolios, Atmel is able to provide the electronics industry with complete system solutions focused on consumer, industrial, security, communications, computing and automotive markets.
A(C) 2009 Atmel Corporation. All Rights Reserved. Atmel(R), Atmel logo and combinations thereof, AVR(R), AVR Studio(R), and others are registered trademarks or trademarks of Atmel Corporation or its subsidiaries. Other terms and product names may be trademarks of others.
Press Contacts: Dr. Susanne van Clewe, Marcom Director Automotive Phone: +49 7131 67-2081, Email: susanne.van-clewe@atmel.com Clive Over, Director of Public Relations Phone: +1 408 436-4305, Email: clive.over@atmel.com
SOURCE Atmel Corporation
------------------------------------------------------------------------------------------------------------------------------------------------------------
(NASDAQ: ATRC) AtriCure, Inc.
BREAKING NEWS!!
AtriCure Announces European Approval for its AtriClip(TM) System
WEST CHESTER, Ohio, Oct 06, 2009 -- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced CE Mark approval for its AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion System. The AtriClip System is designed to safely and effectively exclude the left atrial appendage and is being launched in Europe through a phased approach during the fourth quarter.
The system was successfully utilized this week in multiple European centers during both open-heart and minimally invasive cardiac procedures. The first cases were performed at the University of Zurich in Switzerland by Professor Volkmar Falk and Dr. Sacha Salzberg. "The AtriClip System was intuitive to use and resulted in a safe and complete exclusion of the left atrial appendage," said Professor Falk. "This is a very promising advancement for exclusion of the left atrial appendage. We look forward to further use and evaluation of this system."
"European approval of the AtriClip System represents a major product and clinical milestone for AtriCure," said David J. Drachman, President and Chief Executive Officer. "We believe that the AtriClip System provides a safe, efficient and clinically superior method to exclude the left atrial appendage. This key innovation represents a large and exciting new growth platform and we look forward to full commercial release in Europe and the United States during 2010."
EACTS Satellite Symposium
On October 19, 2009, the AtriClip System will be highlighted during a symposium at the EACTS annual meeting in Vienna, Austria, a meeting for cardio-thoracic surgeons that has over 3,000 physician attendees. The symposium, entitled "The Left Atrial Appendage: Rewards and Challenges," will be lead by Dr. Michael J. Mack, Medical Director of Cardiovascular Surgery, Baylor Healthcare System and Chairman of the Heart Hospital -- Baylor Plano Research Center. Dr. Mack, the principal investigator of the FDA multi-center trial for the AtriClip System, EXCLUDE, will be joined by Dr. Salzberg, the principal investigator of the European trial for the AtriClip System, to discuss their respective clinical trial results using this novel system.
About the Left Atrial Appendage and the AtriClip System
The AtriClip System includes a clip device that is designed to exclude the left atrial appendage, a hollow sac-like structure attached to the heart's left atrium. The left atrial appendage has internal peaks and valleys, or trabeculations. During AF, stagnant blood pools in the trabeculations of the left atrial appendage and is known to form clots that can migrate to other parts of the body. The AtriClip is designed to be implanted from the outside of the heart, avoiding contact with circulating blood and eliminating blood flow between the left atrial appendage and the atria.
About AtriCure, Inc.
AtriCure, Inc. is a medical device company and a leader in developing, manufacturing and selling innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure Isolator(R) bipolar ablation system as a treatment alternative during open-heart surgical procedures to create lesions in cardiac tissue to block the abnormal electrical impulses that cause atrial fibrillation, or AF, a rapid, irregular quivering of the upper chambers of the heart. Additionally, medical journals and leading cardiothoracic surgeons have described the AtriCure Isolator system as a promising treatment alternative for patients who may be candidates for sole-therapy minimally invasive procedures. AF affects more than 5.5 million people worldwide and predisposes them to a five-fold increased risk of stroke. The FDA has cleared the AtriCure Isolator system and AtriCure's multifunctional pen and Coolrail(TM) linear ablation device, for the ablation, or destruction, of cardiac tissue during surgical procedures. Additionally, the FDA has cleared AtriCure's multifunctional pen for temporary pacing, sensing, stimulating and recording during the evaluation of cardiac arrhythmias and AtriCure's Cryo1 system for the cryosurgical treatment of cardiac arrhythmias. To date, the FDA has not cleared or approved AtriCure's products for the treatment of AF.
SOURCE: AtriCure, Inc.
------------------------------------------------------------------------------------------------------------------------------------------------------------
About StockMarketingInc.com
StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by tockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.
CONTACT: StockMarketingInc.com
Tel: +1 866 583 8960
e-mail: info@StockMarketingInc.com
WWW: http://www.StockMarketingInc.com
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
[ Back To TMCnet.com's Homepage ]
|
TMCnet LOGIN
Webinars
